Department of Basic Sciences Pharmacy, Institute of Health Sciences, Van Yuzuncu Yil University, Van, Turkey.
Department of Biochemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, Van, Turkey.
J Food Biochem. 2022 Oct;46(10):e14314. doi: 10.1111/jfbc.14314. Epub 2022 Jul 8.
In this original article, we aimed to assess the ameliorative role of Cyanus depressus (CD) plant ethanolic extract treatment of streptozotocin (STZ)-induced liver, kidney, and pancreas damage in rats. The rats were divided into five groups (n = 7): control, CD, Diabetes mellitus (DM), DM + CD, and DM + glibenclamide (Gly). The DM groups were injected with a single dose of 50 mg/kg STZ intraperitoneally (i.p.). While the CD and DM + CD groups received 400 mg/kg/day intragastrically for 21 days, the DM + Gly group received 3 mg/kg/day of Gly intragastrically throughout the experiment. Statistically significance was accepted as p < .05. According to our liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) data, quinic acid, cosmosiin, nicotiflorin, apigenin, and protocatechuic acid were the major compounds, in descending order. Weekly blood glucose, serum glucose, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and urea, malondialdehyde (MDA) (liver and pancreas), and blood glycosylated hemoglobin % (HbA1c %) were significantly decreased, whereas finally live body weights (LBWs), reduced glutathione (GSH), glutathione S-transferase (GST) and catalase (CAT) (pancreas), and pancreatic islet diameter and area were increased significantly in the CD-treated diabetic group. Moreover, CD administration was found to be effective in the protection of the histology of the liver, kidneys, and pancreatic islets in the STZ-induced rats. Consequently, we concluded that CD administration reduces hyperglycemia, oxidative stress, and histopathology in STZ-induced experimental rats by improving antioxidant defenses. PRACTICAL APPLICATIONS: Today, the prevalence of diabetes is increasing rapidly throughout the world and it causes complications such as kidney damage, blindness, amputations, and cardiovascular diseases. Despite medical technological advances, people's interest in medicinal herbal products is gradually increasing. Biochemical and histopathological findings showed that the use of the plant CD at the determined dose (400 mg/kg/day) in rats with DM by STZ had strong antioxidant and antidiabetic effects. CD may have a drug potential in preventing DM and its complications because of its phytochemical content including some phenolic acids such as quinic acid, cosmosiin, nicotiflorin, apigenin, and protocatechuic acid. Isolation of bioactive compounds from CD and investigation of their therapeutic effects could be planned as further studies.
在这篇原创文章中,我们旨在评估矢车菊素(CD)植物乙醇提取物对链脲佐菌素(STZ)诱导的大鼠肝、肾和胰腺损伤的改善作用。将大鼠分为五组(n=7):对照组、CD 组、糖尿病组(DM)、DM+CD 组和 DM+格列本脲(Gly)组。DM 组通过腹腔内注射 50mg/kg STZ 单次给药。而 CD 和 DM+CD 组连续 21 天每天给予 400mg/kg 灌胃,DM+Gly 组则在整个实验过程中每天给予 3mg/kg 格列本脲灌胃。统计学意义被接受为 p<0.05。根据我们的液相色谱-质谱/质谱(LC-MS/MS)数据,奎尼酸、矢车菊素、野黄芩苷、芹菜素和原儿茶酸是主要化合物,按降序排列。每周血糖、血清葡萄糖、天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、乳酸脱氢酶(LDH)和尿素、丙二醛(MDA)(肝脏和胰腺)以及血液糖化血红蛋白%(HbA1c%)显著降低,而最终体重(LBWs)、还原型谷胱甘肽(GSH)、谷胱甘肽 S-转移酶(GST)和过氧化氢酶(CAT)(胰腺)以及胰腺胰岛直径和面积显著增加在 CD 治疗的糖尿病组中。此外,在 STZ 诱导的大鼠中,CD 给药被发现可有效保护肝脏、肾脏和胰岛的组织学。因此,我们得出结论,CD 给药通过改善抗氧化防御来降低 STZ 诱导的实验大鼠的高血糖、氧化应激和组织病理学。实际应用:如今,糖尿病的患病率在全球范围内迅速增加,它会导致肾脏损伤、失明、截肢和心血管疾病等并发症。尽管医疗技术取得了进步,但人们对草药产品的兴趣却在逐渐增加。生化和组织病理学研究结果表明,在 STZ 诱导的糖尿病大鼠中,以 400mg/kg/天的剂量使用 CD 植物具有很强的抗氧化和抗糖尿病作用。由于 CD 的植物化学物质含量包括一些酚酸,如奎尼酸、矢车菊素、野黄芩苷、芹菜素和原儿茶酸,因此 CD 可能具有预防 DM 及其并发症的药物潜力。可以计划从 CD 中分离生物活性化合物并研究其治疗效果作为进一步的研究。